Regulation by Chemokines of Circulating Dendritic Cell Precursors, and the Formation of Portal Tract–Associated Lymphoid Tissue, in a Granulomatous Liver Disease
Hiroyuki Yoneyama(Io Therapeutics (United States)), Kouji Matsushima(The University of Tokyo), Kenjiro Matsuno(Dokkyo University), Yi Zhang(Fujian Medical University), Sho Ishikawa(The University of Tokyo), Masako Murai(Niigata University), Hitoshi Asakura(Niigata University), Makoto Naito(Nagara Medical Center), Go Hasegawa(Niigata University of Pharmacy and Medical and Life Sciences), Meiji Itakura(Chiba Cancer Center)
Cited by 198
Related Papers
International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
|Pharmacological Reviews|2013|849
Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line.
|The Journal of Experimental Medicine|1989|765
Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation
|Immunity|2021|409
Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma
|Lung Cancer|2013|261
Plasma proteomic profiles predict future dementia in healthy adults
|Nature Aging|2024|258